DATA PLANS
Download historical data for 20 million indicators using your browser.
Subscription Plans
|
Features
API GATEWAY
Direct access to our data from your apps using any programing language.
Features
|
Documentation
Already a user?
Login
Light Mode
Dark Mode
Calendar
News
Markets
Currencies
Stocks
Commodities
Bonds
Crypto
Earnings
Holidays
Indicators
Inflation Rate
Interest Rate
Unemployment Rate
GDP Growth
GDP per Capita
GDP Value
Current Account
Credit Rating
Wages Growth
Gold Reserves
Government Debt
Crude Oil Production
Gasoline Prices
Heatmap Table
More Indicators
Countries
United States
China
Japan
Canada
Australia
Brazil
Russia
India
Euro Area
United Kingdom
Germany
France
Italy
Spain
Switzerland
Singapore
More Countries
Forecasts
Countries
Indicators
Currencies
Stocks
Commodities
Bonds
Crypto
Regeneron Pharmaceuticals | REGN - Trade Creditors
Chart
Quotes
Financials
1Y
5Y
10Y
25Y
MAX
Chart
Column
Line
Area
Spline
Splinearea
Trend
Average(4)
Histogram
Variance
Mean
Maximum
Minimum
Compare
Export
API
Embed
Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.
Features
Questions?
Contact us
Already a Member?
Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.
API Features
Documentation
Interested?
Click here to contact us
Please Paste this Code in your Website
width
height
Preview
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals reported $599.5M in Trade Creditors for its fiscal quarter ending in March of 2023.
Trade Creditors
Change
Date
Agenus
AGEN:US
USD 46.77M
5.83M
Mar/2023
Agios Pharmaceuticals
AGIO:US
USD 8.66M
9.95M
Mar/2023
Alimera Sciences
ALIM:US
USD 9.67M
419K
Mar/2023
Alnylam Pharmaceuticals
ALNY:US
USD 62.24M
35.86M
Mar/2023
Astellas Pharma
4503:JP
JPY 140.24B
6B
Mar/2023
Biogen
BIIB:US
USD 491.2M
300K
Mar/2023
Bluebird Bio
BLUE:US
USD 19.24M
5.86M
Mar/2023
Eli Lilly
LLY:US
USD 2.02B
85.3M
Mar/2023
Esperion Therapeutics
ESPR:US
USD 17.06M
5.98M
Mar/2023
Incyte Corp
INCY:US
USD 55.63M
221.91M
Mar/2023
Intercept Pharmaceuticals
ICPT:US
USD 12.74M
1.49M
Mar/2023
Ionis Pharmaceuticals
IONS:US
USD 10.5M
7.42M
Mar/2023
J&J
JNJ:US
USD 9.91B
1.79B
Mar/2023
Kyowa Hakko Kirin
4151:JP
JPY 66.29B
56.8B
Mar/2023
Moderna Inc
MRNA:US
USD 389M
98M
Mar/2023
Novartis
NOVN:VX
USD 5.43B
280M
Mar/2023
Novartis
NVS:US
USD 5.43B
280M
Mar/2023
Puma Biotechnology
PBYI:US
USD 8.59M
2.15M
Mar/2023
Regeneron Pharmaceuticals
REGN:US
USD 599.5M
10.3M
Mar/2023
Sarepta Therapeutics
SRPT:US
USD 106.71M
10.84M
Mar/2023
Seattle Genetics
SGEN:US
USD 141.48M
66.38M
Mar/2023
Teva Pharmaceutical Industries Ltd
TEVA:IT
USD 2.38B
494M
Mar/2023
Ultragenyx Pharmaceutical
RARE:US
USD 58.98M
15.71M
Mar/2023
Vertex Pharmaceuticals
VRTX:US
USD 323.2M
19.3M
Mar/2023
Financials
Stock Price
Assets
Cash and Equivalent
Cost of Sales
Current Assets
Current Liabilities
Debt
EBIT
EBITDA
Employees
EPS Earnings Per Share
Equity Capital and Reserves
Gross Profit on Sales
Interest Expense on Debt
Interest Income
Loan Capital
Market Capitalization
Net Income
Operating Expenses
Operating Profit
Ordinary Share Capital
PE Price to Earnings
Pre-Tax Profit
Sales Revenues
Selling and Administration Expenses
Stock
Trade Creditors
Trade Debtors